RetinalGenix Technologies (RTGN) Long-Term Deferred Tax (2020 - 2023)
RetinalGenix Technologies (RTGN) reported Long-Term Deferred Tax of $3.3 million for Q4 2023, up 141.69% on a YoY basis from $1.4 million in Q4 2022, and up 141.69% sequentially from $1.4 million in Q4 2022.
RetinalGenix Technologies (RTGN) Long-Term Deferred Tax (2020 - 2023) Analysis & Trends
RetinalGenix Technologies (RTGN) has 4 years of Long-Term Deferred Tax data on file, last reported at $3.3 million in Q4 2023.
- For the quarter ending Q4 2023, Long-Term Deferred Tax rose 141.69% year-over-year to $3.3 million; the trailing twelve-month figure through Dec 2023 stood at $3.3 million (up 141.69% YoY), and the FY2023 full-year result was $3.3 million, up 141.69% from the prior year.
- Long-Term Deferred Tax rose to $3.3 million in Q4 2023, from $1.4 million in the prior quarter.
- In the past five years, Long-Term Deferred Tax ranged from a high of $3.3 million in Q4 2023 to a low of $789000.0 in Q4 2020.
- A 4-year average of $1.7 million and a median of $1.3 million in 2021 frame the typical range for Long-Term Deferred Tax.
- Across the five-year window, Long-Term Deferred Tax climbed 15.0% in 2022 and jumped 141.69% in 2023, its largest moves.
- Tracing RTGN's Long-Term Deferred Tax over 4 years: stood at $789000.0 in 2020, then soared by 51.2% to $1.2 million in 2021, then climbed by 15.0% to $1.4 million in 2022, then soared by 141.69% to $3.3 million in 2023.
- Business Quant data shows RTGN's Long-Term Deferred Tax at $3.3 million in Q4 2023, $1.4 million in Q4 2022, and $1.2 million in Q4 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | RetinalGenix Technologies | 75.02 Mn | 75.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 3.32 Mn |
| Dec 31, 2022 | 1.37 Mn |
| Dec 31, 2021 | 1.19 Mn |
| Dec 31, 2020 | 789,000.00 |